Morgan Stanley Maintains Equal-Weight on Alexion Pharmaceuticals, Raises Price Target to $131

Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $128 to $131.

Benzinga · 01/17/2020 13:16

Morgan Stanley maintains Alexion Pharmaceuticals (NASDAQ:ALXN) with a Equal-Weight and raises the price target from $128 to $131.